Merge Healthcare Inc.  

(Public, NASDAQ:MRGE)   Watch this stock  
Find more results for MRGE
3.29
0.00 (0.00%)
May 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.28 - 3.35
52 week 2.20 - 4.05
Open 3.32
Vol / Avg. 298,434.00/335,457.00
Mkt cap 307.28M
P/E     -
Div/yield     -
EPS -0.36
Shares 93.40M
Beta 0.79
Inst. own 33%
Jul 29, 2013
Q2 2013 Merge Healthcare, Inc. Earnings Release Add to calendar
Jun 18, 2013
Merge Healthcare, Inc. Annual Shareholder Meeting - 11:00AM EDT - Add to calendar
May 6, 2013
Q1 2013 Merge Healthcare, Inc. Earnings Release
May 1, 2013
Q1 2013 Merge Healthcare, Inc. Earnings Conference Call
Feb 19, 2013
Q4 2012 Merge Healthcare, Inc. Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -10.20% -11.58%
Operating margin 8.30% 2.66%
EBITD margin - 12.51%
Return on average assets -5.93% -6.50%
Return on average equity -34.73% -34.08%
Employees 860 -
Carbon Disclosure Rating - -

Address

24th Floor Suite 2435, 200 E. Randolph Street
CHICAGO, IL 60601-6436
United States - Map
+1-312-5656868 (Phone)
+1-312-5656870 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Merge Healthcare Incorporated (Merge) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the challenges in health information exchange, such as the incorporation of medical images and diagnostic information into broader health information technology (IT) applications and the interoperability of software solutions. It provides enterprise imaging solutions for radiology, cardiology, orthopaedics and eye care; a suite of products for clinical trials; software for financial and pre-surgical management, and applications that fuel some of the modality vendors worldwide. It provides enterprise imaging solutions for radiology, cardiology, orthopaedics and eye care; a suite of products for clinical trials; software for financial and pre-surgical management, and applications. On August 4, 2011, it acquired Ophthalmic Imaging Systems (OIS).

Officers and directors

Michael W. Ferro Jr. Chairman of the Board
Age: 45
Bio & Compensation  - Reuters
Justin C. Dearborn CPA President, Chief Financial Officer, Director
Age: 42
Bio & Compensation  - Reuters
Jeffery A. Surges Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
Steve Martin Executive Vice President - Product Solutions
Bio & Compensation  - Reuters
Ann G. Mayberry-French General Counsel, Corporate Secretary
Age: 51
Bio & Compensation  - Reuters
Cheryl Whitaker M.D. Chief Medical Officer
Bio & Compensation  - Reuters
Matthew Maloney Director
Bio & Compensation  - Reuters
Dennis Brown Independent Director
Age: 64
Bio & Compensation  - Reuters
Richard A. Reck Independent Director
Age: 62
Bio & Compensation  - Reuters
Neele E. Stearns Jr Independent Director
Age: 76
Bio & Compensation  - Reuters